Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04783389
Status:
TERMINATED
Last Update Posted:
2023-10-17
First Post:
2021-02-24
Brief Title:
A Study to Evaluate CBP-201 Rademikibart in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Sponsor:
Suzhou Connect Biopharmaceuticals Ltd
Organization:
Suzhou Connect Biopharmaceuticals Ltd
Organization Data
Organization:
Suzhou Connect Biopharmaceuticals Ltd
Class:
INDUSTRY
Study ID:
CBP-201-WW003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Suzhou Connect Biopharmaceuticals Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None